Cancer Education Lectures and Seminars
Since 2003, Cancer Pathways has offered cancer education lectures, at no cost to participants, around the Puget Sound. The topics are cancer-related and have included lectures on specific cancer diagnoses, psycho-social and emotional issues, family-related concerns, integrative medicine, cancer prevention, death and dying, and some of the practical aspects having to do with cancer such as finances, wills, and resources. Our goal is to provide information that empowers people to make informed decisions that directly affect the quality of their lives.
Innovations in Prostate Cancer Therapy
Thursday, September 27th. 7:00-8:30pm
John Corman, MD, will review and discuss innovations in prostate cancer treatment and their potential impact on the growth and treatment of prostate cancer. He will also be available to answer questions regarding the diagnosis, treatment, and management of prostate cancer.
John Corman, MD, is the Medical Director of the Virginia Mason Medical Center Cancer Institute. He received his MD from the Baylor College of Medicine. Dr. Corman's expertise lies in Clinical Research, Surgery, Urology, Kidney and Prostate cancers including robotic prostatectomy, nerve-sparing techniques, and interstitial seed implantation. He is Certified by the American Board of Urology. Dr. Corman has been voted one of Seattle's Top Doctors by both the Seattle Met and Seattle magazines.
Cancer Immunology and Immunotherapy
Thursday, November 8th. 7:00-8:30pm
Recent improvements in our understanding of the human immune system and its manipulation have greatly changed cancer treatment. Although the immune system’s main function is to defend against foreign invaders such as bacteria and viruses, it appears to have little activity against cancer. Cancer is derived from our normal cells (self) and it was always thought that the body was not able to recognize cancer cells as foreign. We have now discovered the many controls that are in place to protect against an immune attack on “self” and have learned how to manipulate the immune system to allow it to attack cancer. Our speaker, Gary Goodman, MD, MS, will give an easy to understand primer on the immune system, its normal function, a historical discussion of the issues with cancer, and discuss the newer immune based treatments and the results of recent clinical trials in this rapidly changing field.
Our speaker, Gary Goodman, MD, MS, has a longstanding record of clinical research in the area of cancer prevention, study design, interpretation of results, biomarker development and therapeutic cancer immunology. He holds a joint membership with the Fred Hutchinson Cancer Research Center and Swedish Cancer Institute. His interest in cancer prevention began in 1978 and he has become a leader in the field. In 1982 Dr. Goodman began CARET, the beta-Carotene And Retinol Efficacy lung cancer preven-on Trial recruiting 18,314 smoking and asbestos–exposed participants nation-wide. He has been instrumental in the conduct of the trial, participant followup and the biorepository management since that time. His interest in cancer immunology began in 1982 with some of the first human trials of monoclonal antibodies in melanoma patients. These studies later expanded to other tumor types using monoclonal antibodies and immunostimulant molecules. Since that time the field of cancer immunology has expanded greatly where the treatment of cancer using the human immune system has become part of standard treatment.